PRCP
CLB icon

Pacific Ridge Capital Partners’s Core Laboratories CLB Stock Holding History

Pacific Ridge Capital Partners’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$646K Buy
55,418
+10,987
+25% +$157K 0.12% 125
2026
Q1 		$746K Buy
44,431
+8
+0% +$143 0.16% 108
2025
Q4 		$712K Buy
44,423
+1,980
+5% +$29.5K 0.16% 112
2025
Q3 		$525K Buy
+42,443
New +$498K 0.12% 120

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Pacific Ridge Capital Partners's CLB Position: Q2 2026 in Review

Pacific Ridge Capital Partners increased its Core Laboratories (CLB) stake by 25% in Q2 2026, buying an estimated $157K and bringing the position to 55,418 shares worth $646K. The position accounts for 0.12% of the portfolio, ranked #125.

Pacific Ridge Capital Partners first reported a position in CLB in Q3 2025 and has held it in 4 quarters since. The position peaked at $746K in Q1 2026. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Pacific Ridge Capital Partners held 55,418 shares of Core Laboratories worth $646K as of Q2 2026.
  • Pacific Ridge Capital Partners bought 10,987 Core Laboratories shares in Q2 2026, an estimated $157K.
  • Core Laboratories made up 0.12% of Pacific Ridge Capital Partners's portfolio in Q2 2026, its #125 holding.
  • Pacific Ridge Capital Partners first reported a position in Core Laboratories in Q3 2025 and has held it in 4 quarters since.
  • Pacific Ridge Capital Partners's Core Laboratories position peaked at $746K in Q1 2026.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Pacific Ridge Capital Partners's 13F filing for Q2 2026, filed 12 Aug 2026.